Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (4611)	9/24/1998 2:18:00 PM
From: Money Maker (MM)	Read Replies (1) \| Respond to of 119973

AOL and AMZN, my eyes on them, waiting for new high in short term. Next Tuesday, FED will show me the money....:) MM

To: TokyoMex who wrote (4611)	9/24/1998 3:29:00 PM
From: lightfoot	Respond to of 119973

September 24, 1:39 pm Eastern Time(Nasdaq: CYPH ) announced today that Patent claims for anti-sense technology developed by Dr. Donald Gray at University of Texas at Dallas were approved. Cytoclonal has exclusive worldwide rights to the technology. Anti-sense technology is designed to regulate genes involved in different diseases. For example, if a cancer related gene is involved in the cancer state, an anti-sense reagent could be utilized to turn the cancer gene off and prevent cancer cells from proliferating. An anti-sense reagent is a synthetic gene fragment which binds to the gene and thereby regulates it. This looks like the news Big Dog was touting for CYGS HA HA This really is a breathrough in this industry of cancer fighting drugs. I got interested in it because of the hype on CYGS, the technology of antisense is sound and now patented delivery. Good news for cancer patients.